Ameritas Investment Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ameritas Investment Partners’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.3K	Hold	13,773	–	–	﹤0.01%	2106
2025 Q4	$46.4K	Hold	13,773	–	–	﹤0.01%	2180
2025 Q3	$18K	Hold	13,773	–	–	﹤0.01%	2704
2025 Q2	$9.88K	Hold	13,773	–	–	﹤0.01%	2986
2025 Q1	$20.2K	Hold	13,773	–	–	﹤0.01%	2551
2024 Q4	$61K	Hold	13,773	–	–	﹤0.01%	2065
2024 Q3	$56.7K	Hold	13,773	–	–	﹤0.01%	2116
2024 Q2	$89.8K	Hold	13,773	–	–	﹤0.01%	1797
2024 Q1	$120K	Hold	13,773	–	–	﹤0.01%	1623
2023 Q4	$158K	Hold	13,773	–	–	0.01%	1438
2023 Q3	$133K	Buy	13,773 +2,326	+20%	+$22.8K	0.01%	1456
2023 Q2	$122K	Buy	11,447 +1,196	+12%	+$12.9K	﹤0.01%	1464
2023 Q1	$108K	Hold	10,251	–	–	﹤0.01%	1486
2022 Q4	$117K	Hold	10,251	–	–	﹤0.01%	1489
2022 Q3	$106K	Hold	10,251	–	–	﹤0.01%	1447
2022 Q2	$118K	Sell	10,251 -1,140	-10%	-$13.4K	0.01%	1396
2022 Q1	$143K	Hold	11,391	–	–	0.01%	1402
2021 Q4	$133K	Hold	11,391	–	–	﹤0.01%	1515
2021 Q3	$149K	Hold	11,391	–	–	0.01%	1428
2021 Q2	$147K	Sell	11,391 -1,589	-12%	-$18.2K	0.01%	1479
2021 Q1	$145K	Sell	12,980 -833	-6%	-$8.8K	0.01%	1424
2020 Q4	$157K	Hold	13,813	–	–	0.01%	1284
2020 Q3	$124K	Hold	13,813	–	–	0.01%	1301
2020 Q2	$143K	Hold	13,813	–	–	0.01%	1199
2020 Q1	$139K	Buy	13,813 +727	+6%	+$8.54K	0.01%	1089
2019 Q4	$174K	Hold	13,086	–	–	0.01%	1173
2019 Q3	$112K	Hold	13,086	–	–	0.01%	1397
2019 Q2	$143K	Sell	13,086 -1,028	-7%	-$11.5K	0.01%	1268
2019 Q1	$160K	Hold	14,114	–	–	0.01%	1179
2018 Q4	$122K	Hold	14,114	–	–	0.01%	1251
2018 Q3	$218K	Hold	14,114	–	–	0.01%	1032
2018 Q2	$226K	Hold	14,114	–	–	0.01%	1007
2018 Q1	$182K	Hold	14,114	–	–	0.01%	1130
2017 Q4	$177K	Hold	14,114	–	–	0.01%	1153
2017 Q3	$188K	Hold	14,114	–	–	0.01%	1092
2017 Q2	$223K	Buy	14,114 +773	+6%	+$11.2K	0.01%	1002
2017 Q1	$191K	Hold	13,341	–	–	0.01%	1090
2016 Q4	$171K	Hold	13,341	–	–	0.01%	1045
2016 Q3	$177K	Buy	+13,341	New	+$156K	0.01%	1022
2015 Q2	–	Sell	-12,785	Closed	-$171K	–	1189
2015 Q1	$171K	Hold	12,785	–	–	0.01%	1020
2014 Q4	$164K	Hold	12,785	–	–	0.01%	1003
2014 Q3	$139K	Hold	12,785	–	–	0.01%	987
2014 Q2	$164K	Buy	+12,785	New	+$139K	0.01%	1016

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameritas Investment Partners's IRWD Position: Q1 2026 in Review

Ameritas Investment Partners held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 13,773 shares worth $48.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Ameritas Investment Partners first reported a position in IRWD in Q2 2014 and has held it in 43 quarters since. The position peaked at $226K in Q2 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Ameritas Investment Partners held 13,773 shares of Ironwood Pharmaceuticals worth $48.3K as of Q1 2026.
Ameritas Investment Partners left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2106 holding.
Ameritas Investment Partners first reported a position in Ironwood Pharmaceuticals in Q2 2014 and has held it in 43 quarters since.
Ameritas Investment Partners's Ironwood Pharmaceuticals position peaked at $226K in Q2 2018.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.